AUGMENTIN 400MG/5ML + 57MG/5 ML POR PLV SUS 70ML + LŽ

What is the maximum co-payment for AUGMENTIN?

If the insurance company contributes, the maximum co-payment is 50,55 Kč. The maximum pharmacy price is 127,65 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does AUGMENTIN have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

77,10 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe AUGMENTIN?

Prescription is not conditional on a medical specialization.

What is the composition of AUGMENTIN?

Trihydrát amoxicilinu (459,17 mg), amoxicilin (400 mg), kalium-klavulanát (67,9 mg), kyselina klavulanová (57 mg), oxid křemičitý, hypromelosa, koloidní bezvodý oxid křemičitý, xanthanová klovatina, neznámá látka s kódem 7372, kyselina jantarová, neznámá látka s kódem 21091, neznámá látka s kódem 3763, neznámá látka s kódem 1915. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to AUGMENTIN?

The medicine belongs to ATC group J01CR02 – AMOXICILIN A INHIBITOR BETA-LAKTAMASY. Medicines with the same active substance can be found here.

Who manufactures AUGMENTIN?

GlaxoSmithKline Trading Services Limited, Dublin (IRL)

Is the medicine in shortage?

The latest report from the manufacturer is from 13. 12. 2022. Production was terminated with effect from 14. 12. 2022. The manufacturer lists medicines with the following code as a potential substitute: